Professor Kevin Brindle joins Ellie Wolmark to discuss his life's work in imaging research as he reaches retirement. Kevin is particularly interested in metabolic imaging. His research group has developed novel magnetic resonance-based molecular imaging techniques to detect the early responses of tumours to therapy, with a view to translating these into clinical application. He talks about how he got into this topic in the first place, his amazing contributions to the field over the past four decades, and about how his techniques can be translated into the clinic to impact patient treatment.

Kevin is Emeritus Professor of Biomedical Magnetic Resonance in the Department of Biochemistry and a Senior Group Leader in the CRUK Cambridge Institute at the University of Cambridge, UK. He is also a Fellow of the Academy of Medical Sciences and of the Royal Society.

Integrated Cancer Medicine: Research in Focus

Kevin Brindle – Reflections on a lifetime in imaging research

The Cancer Research UK Cambridge Centre unites over 1,000 world-leading biologists, chemists, physicists, engineers, mathematicians, computer scientists, clinicians, nurses and allied healthcare professionals from across Cambridge, UK to tackle cancer from every angle.

Our mission is to end death and disease caused by cancer through research, treatment and education. We are detecting cancer at its earliest stage and are developing personalised treatments for every patient through facilitating new collaborations and driving the translation of new scientific discoveries into clinical applications to improve patient care. By working together across a range of different disciplines, our members are breaking down the barriers between the laboratory and the clinic, enabling patients to benefit from the latest innovations in cancer science.

New tracks tagged #Cancer Imaging